This webinar offers essential tools and insights to help organisations confidently navigate the BioSecure Act, ensuring they ...

Amid a push to phase out animal testing, Charles River’s Steve Bulera notes that the implementation of alternative methods ...

Aquestive Therapeutics has made a strategic funding agreement worth $75m with RTW Investments to support the potential launch ...

Gilead will integrate Interius, the first biotech to push an in vivo CAR-T therapy into the clinic, into its cell therapy ...

Bavarian Nordic bolstered its cash reserves with a $160m sale of a priority review voucher in June 2025. The company has now ...

The FDA has granted approval for Ionis Pharmaceuticals’ Dawnzera (donidalorsen), for use in preventing hereditary angioedema ...

Before Novo arrived as its owner, issues at the Bloomington facility caused a two-month delay for Eylea HD’s FDA approval ...

Madrigal Pharmaceuticals’ Rezdiffra has been approved in Europe for the treatment of MASH with moderate to advanced liver ...

Tariff rates on generic pharmaceutical products imported from the EU to the US will now be “effectively zero or close to zero ...

Santen has signed an agreement with RemeGen for the RC28-E intravitreal injection, a dual-target fusion protein for retinal ...

Novo is far from the only big pharma company bolstering DTC medicine offerings. Novo’s main rival in the GLP-1RA arena, Eli ...